prevent post-operative infections because the patient had had severe complications from the previous operation of the perinephritic abscess, an exchange blood transfusion was performed immediately after the surgical operation of hepatic and intraabdominal abscesses. A pathologic study showed that these abscesses were caused by Staphylococcus aureus and around them small amounts of PMN had infiltrated.
As shown in Figure 1 , the chemotactic movement of the patient's PMN apparently improved within 48 h after the exchange blood transfusion by the skin window method (9) . The effect, however, disappeared 1 wk after the transfusion. The almost identical result was obtained at repeated exchange blood transfusions and plasma exchange (Fig. 1) . The clinical course of the patient after the operation was without further complications. The blood obtained at exchange blood transfusion was used for further studies.
The presence of chemotactic inhibitors was detected in the patient's serum by the same technique at ages of g4/u yr and 11 yr, when a pulmonary abscess recurred.
MATERIALS AND METHODS
Preparations of PMN and rnonocytes. Heparinized blood was obtained from the patient and the normal volunteers. Fractions of mononuclear cells and PMN were separated on Ficoll-Conray (specific gravity, 1.078) gradient as described earlier (2) . The first fraction contained almost all parts of monocytes, but was contaminated with 70-80% lymphocyte. Further purification was not performed because the presence of lymphocyte had no influence on monocyte chemotaxis (20) . The second fraction consisted of more than 95% of PMN. Each fraction was washed two times with buffered saline (pH 7.4) and resuspended in RPMI 1640 (Gibco Lab., NY) containing 5% fetal calf serum at a density 2 x lo5 cell/ml in monocytes and 5 x 10' cell/ml in PMN.
Measurement of cyclic AMP and cyclic GMP in PMN. Cyclic AMP and cyclic GMP were measured using commercially available kit (Yamasa Shoyu Co., Tokyo).
Preparation of chernoattractant. Culture filtrate of E. coli was prepared by the method of Ward et al. (22) . E. coli was grown at 37°C for 24 h in medium TC-199. The culture medium was centrifuged at 10,000 rev/min for 30 min and passed through 0.45-pm Millipore filter. Zymosan-activated serum was prepared by the method of Cates et al. (4) . Serum obtained from normal (8) . After 7 h, the number of leukocytes that migrated into the skin window chamber, which was filled with the patient's or control serum at the test time, was counted, and the percentage of the former number to the latter number was calculated. (M), the first exchange blood transfusion; (0--a), the second exchange blood transfusion; and (x-----x), plasma exchange.
volunteers was pooled, incubated with zymosan (25 mg/ml) (Sigma Chemical Co., St Louis, MO) at 37°C for 30 min and centrifuged at 500 g for 10 min. The supernatant was heated at 56°C for 30 min. Both E. coli culture filtrate and zymosanactivated serum were stored at -70°C and used after dilution in an appropriate concentration.
Synthesized chemotactic peptide f-Met-Leu-Phe was purchased from Protein Research Foundation, Osaka, Japan.
PMN chernotaxis. Chemotaxis using the Boyden chamber was studied according to the method of Horwitz and Garrett (13), using polycarbonate filter (Nuclepore filter; General Electric Co., NY) 2-pm pore size. The upper chamber was filled with 5 x lo5 cells suspended in RPMI 1640 containing 5% fetal calf serum and the lower chamber was filled with 1.0 ml of medium containing chemoattractant. Chemotactic activity was displayed with the number of migrated granulocytes. In order to test an inhibitory activity of the patient's serum and partial purified factor, these were added to the lower chamber. This method was practical and convenient, and the results obtained were similar to each other when these were added to the upper or the lower chamber. The percentage inhibition of PMN was calculated by the formula: 100 x (1 -number of migrated PMN in the presence of patient's serum/number of migrated PMN in the presence of control serum).
Random mobility. Random mobility was tested using the Boyden chamber with buffered saline without chemoattractant in the lower chamber.
Monocyte chernotaxis. Monocyte chemotaxis was studied by the Boyden chamber using 5-pm pore polycarbonate filter (12) . The upper chamber was filled with 2 x lo5 cells and the lower chamber with 1.0 ml of medium containing zymosan-activated serum (10%) and test sample.
Digestive activity of synthetic peptide. f. Met-Le~-[~HlPhe (specific activity, 46.4 Ci/mol) was purchased from New England Nuclear Corp., purified on Dowex 50 W X 2 with 0.01 N HCl, stored at 4"C, and used after neutralizing with 0.1 N NaOH as described (17) . The 0.05 pCi of labeled peptide M) was incubated with 20 p1 of either the patient's or control's serum at 37°C for 2 h. After incubation the medium was deproteinized with acetone and lyophilized. In order to detect f. Met-Le~-[~Hl Phe and its digested products, ascending paperchromatography was used with a solvent system of n-butano1:acetic acid:H20, 3: 1: 1 (16) . After development, the chromatograms were cut into 1-cm strips, which were placed in vials and counted by liquid scintillation counter (Pakard, TRI-CARB, B 2450) in a ACS I1 (Amersham).
Gel filtration. A Sephadex G-200 column, 2.9 X 90 cm was equilibrated with 0.04 M, pH 7.4 phosphate buffered saline at 4°C. The column was calibrated with standard molecular weight marker proteins. Three milliliters of the control or patient's serum was layered on the gel and eluated with phosphate buffered saline. The eluate was fractionated and assayed for chemotactic inhibitory activity. The percentage inhibition was calculated by the formula described above, where each corresponding fraction was used as a control and a test sample. IgE content in these fractions was measured by enzyme immunoassay method using commercially available kit (Kainos Laboratories, Inc., Tokyo). Chernotaxis of patient and control PMN. Random mobility and chemotactic movement of the patient's and control's PMN were similar when these were washed two times with buffered saline (Table 1 ). Similar observations were made when washing was done, after the incubation with patient's serum at 37°C for 30 min (the data was not shown); however, in the presence of patient's serum (lo%), chemotaxis of normal PMN was impaired toward all of three chemoattractants tested (Table 2) . Using five different normal donors, this observation was confirmed. The degree of inhibitory effect of patient's serum was dose-dependent as shown in Figure 2 where, as the amount of control serum was replaced with increasing amounts of the patient's serum, the number of mobile PMN toward synthetic peptide was reduced. Figure 3 displays the chemotaxis of PMN at varying concentrations of f.Met-Leu-Phe (1 x lo-* to 6 x lo-' M). The peptide concentration to obtain the maximum chemotaxis was identical, amounting to 8 x lo-' M in the presence of both the control and the patient's serum (5%), but the maximum number of cell movements was clearly reduced in the latter situation.
RESULTS

Cyclic AMP and cyclic GMP in the patient
Chemotaxis of patient's and control monocyte. Random mo- bility and chemotactic movement of patient's and control monocytes were similar. In the presence of patient serum, chemotaxis of normal monocytes was impaired toward zymosan-activated serum (Fig. 4) . Digestive activity on labeled synthetic peptide. The radioactivities of the incubated samples containing patient's and control serum, appeared in a peak of f-Met-Leu-Phe with a different Rf value of presumed products of Met-Leu-Phe, Leu-Phe, and Phe. So neither the patient's nor the control serum had any activity of f. Met-Leu-Phe digestion.
Concentration of chemotactic peptide
Partial purification. Chemotactic inhibitory activity of the patient's serum was stable when incubated at 56°C for 30 min. As shown in Figure 5 , two peaks of percentage inhibition were observed in the fractionated samples of patient's serum. The first peak corresponded to an approximately 30,000-40,000 dalton molecular weight and the second peak was probably that of the one absorbed with Sephadex G-200. Neither of them had IgE antigenicity. IgE peak was found in at the respected site of the fraction. Fig. 5 . Chromatography of patient's serum o n Sephadex G 200. Alternate tubes was assayed for chemotactic inhibitory factor by the Boyden chamber method. 1) blue dextran; 2) albumin; and 3) cytochrom C.
Fraction numbers
DISCUSSION
Our clinical and laboratory observations include I) severe recurrent infection caused by Staphlococcus aureus and Hemophilus influenzae, accompanied by allergic rash and candidiasis, 2) elevated serum concentration of IgE and 3) impaired PMN chemotactic movement by skin window method. These observations indicate that the patient was suffering from HIE (1, 3, 5, 10, 1 1, 17, 21). Her other defense mechanisms against infection, including cellular and humoral immunity and phagocytosis and bactericidal capacity of PMN, were normal. Defective chemotaxis, as found in other patients with HIE (1, 5, 10, 11, 17, and 21), appeared to be a major factor responsible for the recurrent infection.
In our patient, PMN functions were normal. Cyclic AMP and cyciic GMP concentration in the patient's PMN were within normal limits. In vivo movement of the patient's PMN was impaired and defective PMN chemotaxis was normalized within 48 h after exchange blood transfusion or plasma exchange by the in vivo study using the skin window method. The study of the patient's serum, obtained by exchange blood transfusion, revealed that the patient's serum caused an impaired chemotactic movement of normal PMN (Table l) , the degree of impairment being dose-dependent of patient's serum (Fig. 2) . After washing the patient's and control's PMN, which were incubated with patient's serum in advance, the PMN chemotactic movement returned to normal. In addition, the patient's serum had no digestive activity of f. Met-Leu-Phe peptide. These results demonstrate that there is an inhibitor of chemotaxis or an inactivator of chemotactic factor in her serum, and the effect of such substance seems to be reversible. The patient's serum inhibited chemotaxis of normal PMN toward three different factors as shown in Table 2 .
These observations suggest that the impaired chemotactic movement is attributable to an inhibitor of chemotaxis but not an inactivator of chemotactic factor. Another possible interpretation may be that the mechanism of inhibitory chemotaxis in the patient could be involved in the postreceptor site of PMN movement. This possibility was supported by our observation that the concentration of f.Met-Leu-Phe needed to obtain the maximum chemotactic movement of PMN was 8 x lo-' M in the presence of both control and patient's serum. In other words, the maximum movement did not shift to a lower concentration of the chemotactic peptide (14) .
In earlier studies of HIE, it was reported that the cause of defective chemotactic movement existed in patient's PMN ( In their assay system, the incubated PMN with HIE chemotactic inhibitor was washed with buffered saline before placing them in the Boyden chamber, and, therefore, the inhibitory effect of their factor seemed to be irreversible. On the other hand, the effect of our patient's inhibitor was reversible, as discussed above. Molecular weight of both factors appeared to be different and further study is necessary. Because the partially purified inhibitor in the present case had no antigenicity toward IgE, a relationship between elevation of serum IgE and the inhibitory factor is still obscure. Further characterization, origin, and functioning point of our patient's inhibitor should be studied in the future.
Cardiac Function and Myocardial Metabolism during Tachycardia Induced by Atrial and Ventricular Pacing KATSURO IGARASHI'IO)
Department of Pedialrics, Hirosaki University, School of Medicine, Hirosaki, Japan
Summary
We studied atrial and ventricular pacing-elicited tachycardia in mongrel adult dogs to evaluate ensuing changes in cardiac function and myocardial metabolism. The aortic pressure, left ventricular pressure, and left ventricular end diastolic pressure were measured under anesthesia. Using an electromagnetic flowmeter, coronary blood flow and aortic blood flow were recorded simultaneously with the recording of ECG. Atrial and ventricular pacing (1.5 times the basic heart beat) were performed using a catheter introduced via the jugular vein and positioned in the coronary venous sinus.
Aortic blood and coronary venous blood were sampled for determination of blood oxygen concentrations and lactic acid concentrations. The results showed that oxygen extraction changed little compared with the control study on atrial pacing (AP) and ventricular pacing (VP) whereas the lactate uptake showed little change in the AP control study but decreased slightly in the VP study. It appears that aerobic metabolism occurs during both AP and VP when the pacing rate is not more than 1.5 times the basic heart beat.
Abbreviations ABF, aortic blood flow AP, atrial pacing CBF, coronary blood flow HR, heart rate LVEDV, left ventricular end diastolic volume PAO, aortic pressure PLv, left ventricular pressure Vol. 18, No. 4, 1984 Printed in U. S. A.
PLVED, left ventricular end diastolic pressure VP, ventricular pacing
Along with the advances in the treatment and diagnosis of heart diseases, there has been progress in artificial pacemakers. The pacemaker is now used frequently for the treatment and prevention of arrhythmia in both children and adults. Although previous studies have shown clearly that AP is more physiologic and desirable than VP, there are some cases which necessitate the use of VP because of the condition of the illness (1, 4, 6 ).
There is little opportunity to investigate clinically a tachycardiac state that is maintained by AP or VP for an adequate length of time. An attempt to learn to what extent tachycardia can be maintained by AP or VP, even though nonphysiologic, is by no means useless. From such a viewpoint, we induced experimentally tachycardia by AP and VP in mongrel adult dogs and studied changes in cardiac function and myocardial metabolism.
SUBJECTS AND METHODS
Ten mongrel dogs weighing 14-24 kg were anesthetized by intravenous injection of pentobarbital (30 mglkg). After intratracheal intubation, a ventilator was used to achieve a constant pH and PO2 in arterial blood.
With the animals fixed in a supine position, a median incision was made. The pericardial membrane was cut widely from the center to the apex. As shown in Figure 1 , a catheter was introduced from the femoral artery and positioned in the arch of the aorta and left ventricle. The catheter was to a Statham P23Db transducer for measuring the PAo, PLV, and PLVED.
